Our identification of the novel cancer-promoting function of Fas in the upregulation of nuclear EGFR and STAT3 signaling along with our previous observation that Fas is upregulated in some types of tumors13 suggest that the pro-survival pY-Fas may be a valuable prognostic marker as well as a therapeutic target. This evidence concerns the gene STAT3 and cancer.